128 related articles for article (PubMed ID: 2730019)
1. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
3. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
4. [Imaging of malignant melanoma with In-111-labeled monoclonal antibody (ZME-018) and Ga-67 scintigraphy].
Murakami K; Minoshima S; Uno K; Arimizu N; Kobayashi M; Fujita M; Okamoto S; Ikehira H; Fukuda H; Tateno Y
Kaku Igaku; 1989 Jan; 26(1):113-9. PubMed ID: 2724630
[No Abstract] [Full Text] [Related]
5. [Radioimmunoimaging of malignant melanoma with In-111-labeled monoclonal antibodies 96.5 and ZME 018].
Oyamada H; Ishihara K; Fukukita H; Hayasaka K
Kaku Igaku; 1989 Dec; 26(12):1503-12. PubMed ID: 2622081
[TBL] [Abstract][Full Text] [Related]
6. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.
Macey DJ; Denardo SJ; Denardo GL; Goodnight JK; Unger MW
Am J Physiol Imaging; 1988; 3(1):1-6. PubMed ID: 3390350
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
8. In-111 monoclonal antibody versus Ga-67 citrate and Tc-99m SC subtraction in a patient with malignant melanoma.
Bradfield HA; Tauxe WN; Levine G; Kirkwood JM; Klein H; Mochizuki T
Clin Nucl Med; 1994 Aug; 19(8):703-7. PubMed ID: 7955751
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoimaging in malignant melanoma with monoclonal antibodies.
Repetto L; Scopinaro G; Michelotti A; Claudiani F; Fusco V; Grimaldi A; Sertoli MR; Rosso R
Oncology; 1988; 45(5):392-5. PubMed ID: 3412750
[TBL] [Abstract][Full Text] [Related]
12. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
[TBL] [Abstract][Full Text] [Related]
13. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
14. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
[TBL] [Abstract][Full Text] [Related]
15. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Arano Y; Miyachi Y; Kashihara-Sawami M; Imamura S
Jpn J Cancer Res; 1988 Aug; 79(8):973-81. PubMed ID: 3141332
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Halpern SE; Haindl W; Beauregard J; Hagan P; Clutter M; Amox D; Merchant B; Unger M; Mongovi C; Bartholomew R
Radiology; 1988 Aug; 168(2):529-36. PubMed ID: 3393677
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
[TBL] [Abstract][Full Text] [Related]
18. Intrapatient and interpatient comparison of tumor size and monoclonal antibody uptake in melanoma.
Cornelius EA; Neumann RD; Zoghbi SS; Kirkwood JM; Ernstoff MS; Unger MM
Clin Nucl Med; 1988 Apr; 13(4):243-9. PubMed ID: 3370893
[TBL] [Abstract][Full Text] [Related]
19. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
